To assess the effect of saroglitazar and pioglitazone on non alcoholic fatty liver disease in type 2 diabetes mellitus patients
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract is not available.
newline